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Background: The health effects of short-term exposure to ambient ultrafine particles in micro-environments are still
under investigation.
Methods: Sixty-four individuals with type 2 diabetes and impaired glucose tolerance recorded ambulatory
electrocardiograms over five to six hours on 191 occasions in a panel study in Augsburg, Germany. Personal
exposure to particle number concentrations (PNC) was monitored for each individual on 5-minute basis concurrently
and particulate matter with an aerodynamic diameter < 2.5 μm (PM2.5) was acquired from a central monitoring site on
an hourly basis.
Results: More than 11,000 5-minute intervals were available for heart rate and measures of heart rate variability
including SDNN (standard deviation of NN intervals). A concurrent decrease in 5-minute SDNN of −0.56% (95%
confidence limits (CI): −1.02%; −0.09%) and a 5-minute delayed increase in heart rate of 0.23 % (95% CI: 0.11%;
0.36%) was observed with an increase in personal PNC of 16,000 per cm3 in additive mixed models. Models evaluating
the association of concurrent 5-minute personal PNC and of 1-hour PM2.5 showed independent effects on SDNN.
Conclusion: The data suggest that freshly emitted ultrafine particles and aged fine particulate matter are both
associated with changes in cardiac function in individuals with type 2 diabetes and impaired glucose tolerance in
urban areas.
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Over the past decade, ambient particulate matter has
been established as a likely causal risk factor for cardiovas-
cular disease morbidity and mortality [1]. In particular, ex-
acerbation of cardiovascular disease has been observed
within individuals with diabetes during episodes of high
ambient air pollution exposures [2-4]. It has been noted
that ambient particles [5,6] as well as exposure to traffic
[7,8] might trigger myocardial infarctions within one or* Correspondence: peters@helmholtz-muenchen.de
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unless otherwise stated.two hours. It is hypothesized that these associations may
be a consequence of a direct effect on the electric system
of the heart [1]. The effects of air pollution on heart rate
(HR) and heart rate variability (HRV) were extensively
studied [1] since Pope et al. [9,10], Peters et al. [11], and
Gold et al. [12] initially reported these associations. The
most consistent evidence with respect to cardiovascular
disease exists for fine particulate matter with an aero-
dynamic diameter smaller than 2.5 μm (PM2.5) [1]. Espe-
cially, particles from mobile sources are suggested to be
linked strongly to cardiovascular disease exacerbation
[13]. Particles from emitted mobile sources are much
smaller, mostly in the ultrafine range below 100 nm and
have the potential to act systemically in organisms [14,15].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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carbon particles suggested altered autonomic function
during the exposure in subjects with type 2 diabetes
[16]. The study presented here aimed to assess the im-
mediate impact of personal exposure particle to number
concentrations (PNC) on HR and HRV measured by
ambulatory electrocardiograms (ECG) during five to six
hour periods in individuals with diagnosed type 2 dia-
betes or impaired glucose tolerance (IGT). Specifically,
we assess the impact of personally measured PNC dur-
ing the morning hours on heart rate variability. We build
on previous analyses that assessed the association be-
tween centrally monitored ambient air pollution and car-
diac function within the same study [17]. We had
previously reported associations between 1-hour PM2.5Table 1 Description of study participants and 5-minute ECG m
All (N = 64) Typ
Mean (SD)
Age (years) 66.0 (8.1)
BMI (kg/m2) 30.0 (4.7)
N (%)
BMI (kg/m2) ≤30 34 (53)
>30 30 (47)
Smoking never smoker 26 (41)
ex smoker 37 (58)
occasional smoker 1 (2)
Employed no 50 (78)
yes 14 (22)
HbA1c <6.5% 49 (77)
≥6.5% 15 (23)
History of Coronary heart disease 4 (6)
Angina pectoris 5 (8)
Myocardial infarction 6 (9)
Hypertension 41 (64)
None of these diseases 21 (33)
Medication use Antidiabetics 18 (28)
Beta blockers 19 (30)
Statins 13 (20)
None of the above 28 (44)
ECG N Mean (SD) N
5 min-intervals HR 14,874 79.3 (15.6) 7,31
RMSSD 14,874 30.8 (30.1) 7,31
SDNN 14,874 47.1 (25.1) 7,31
1 h-intervals HR 1,203 79.1 (14.4) 597
RMSSD 1,203 33.9 (31.7) 597
SDNN 1,203 76.7 (27.1) 597
IGT: impared glucose tolerance, SD: standard deviation, BMI: body mass index, HR: h
deviation of NN-intervals, at-test, bChi-square test, cFisher’s exact test.
Antidiabetic medications include: insulins and analogues for injection and inhalatioand decreased heart rate variability upon concurrent ex-
posure as well as exposures occurring up to 4 hours be-
fore the ECG recording.
Results and discussion
Patient characteristics
Sixty-four non-smoking panel members were recruited
for repeated measurements of personal exposure to PNC
and parallel ECG recording. Table 1 describes the base-
line characteristics of the 32 individuals with confirmed
diagnosis of type 2 diabetes and 32 individuals with IGT
recruited based on the KORA F4 study [18,19]. No dif-
ferences were observed between the type 2 diabetes pa-
tients and the individuals with IGT concerning their age,
gender, body mass index or disease history. Glycosylatedeasures
e 2 diabetes (N = 32) IGT (N = 32) p-value
Mean (SD) Mean (SD)
66.8 (6.7) 65.3 (9.4) 0.47a
30.8 (4.3) 29.3 (4.9) 0.18a
N (%) N (%)
15 (47) 19 (59) 0.32b
17 (53) 13 (41)
10 (31) 16 (50) 0.20c
21 (66) 16 (50)
1 (3) 0 (0)
27 (84) 23 (72) 0.23b
5 (16) 9 (28)
18 (56) 31 (97) <0.0001c
14 (44) 1 (3)
3 (9) 1 (3) 0.61c
2 (6) 3 (9) 1.00c
5 (16) 1 (3) 0.20c
21 (66) 20 (63) 0.79b
9 (28) 12 (38) 0.42b
17 (53) 1 (3) <0.0001c
12 (38) 7 (22) 0.17b
10 (31) 3 (9) 0.06c
6 (19) 22 (69) <0.0001c
Mean (SD) N Mean (SD)
2 77.7 (15.6) 7,562 80.8 (15.4) <0.0001a
2 28.0 (27.3) 7,562 33.5 (32.3) <0.0001a
2 45.9 (24.6) 7,562 48.2 (25.5) <0.0001a
77.3 (14.4) 606 80.8 (14.1) <0.0001a
32.5 (32.2) 606 35.1 (31.2) 0.16a
77.5 (26.0) 606 76.0 (28.2) 0.32a
eart rate, RMSSD: root mean square of successive differences, SDNN: standard
n.
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were more frequently observed in individuals with dia-
betes than those with IGT. Diabetes prescriptions were
taken by more than half of the participants with diabetes
and one participant with IGT. More than 14,000 re-
peated 5-minute ECG measures and more than 1,200 1-
hour ECG measures were available (Table 1). Patients
with diabetes had lower HR and HRV on a 5-minute
basis. This different was no longer apparent for HRV
based on 1-hour ECG recordings.
Personal exposures to particle number concentrations
Table 2 describes the distribution of the personal PNC
measurements and the distribution of particle concen-
trations at the central monitoring site. Substantially
higher variation in personal PNC was observed during
personal monitoring compared to the background level
(Table 2). Figure 1 describes an example indicating that
elevated levels of PNC may occur during times spent in
traffic, while indoor concentrations may be substantially
lower in the absence of indoor sources. Elevated per-
sonal PNC were observed when individuals spent time
in traffic (median = 17,884 cm−3, N = 3,523), when cook-
ing (median = 43,612 cm−3, N = 285) or exposed to envir-
onmental tobacco smoke (ETS) (median = 21,929 cm−3,
N = 148). In contrast, personal PNC concentrations were
lower during times spent at home without cooking or
ETS exposure (median = 8,833 cm−3, N = 6,930). By de-
sign of the study, participants were commuting within
the urban area of Augsburg in the morning and midday
hours. Thereby, personal exposures were impacted by
the morning rush-hour as well as by lower traffic volumes
during midday and were there deviating from concentra-
tions measured at an urban background monitoring site
within the city center. Subject-specific Spearman correl-
ation coefficients between 1-hour personal PNC concen-
trations and 1-hour ambient ultrafine particles (UFP) had
a median of 0.35 and ranged from −0.60 at the 10thTable 2 Description of personal 5-minute particle measureme
measurements and meteorology recorded between March 20
N Mean ± SD Min
Personal measurements of PNC (5-minute averages)
PNC [N/cm3] 11,872 20,822 ± 39,233 521
Ambient measurements at stationary monitoring site (1-hour averages
UFP [N/cm3] 14,699 9,518 ± 6,902 937
ACP [N/cm3] 14,699 2,060 ± 1,535 88
PM10 [μg/m
3] 15,466 18.3 ± 14.1 0.0
PM2.5 [μg/m
3] 15,461 13.7 ± 11.2 0.0
Air temperature [°C] 15,398 10.8 ± 7.9 −8.4
Relative humidity [%] 15,398 76.9 ± 18.3 21.0
SD: standard deviation, IQR: interquartile range, PNC: Particle number concentration
particulate matter with an aerodynamic diameter <2.5 μm, ACP: accumulation modpercentile to 0.90 at the 90th percentile. Personally mea-
sured PNC characterise the exposure to mobile source
emissions or other sources of freshly emitted particles and
are determined by the personal activities as well as me-
teorological influences in the region of Augsburg,
Germany [20,21].
Ambient UFP were only moderately correlated with
PM10 and PM2.5 measured at the same central monitor-
ing site (spearman correlation coefficients of 0.49 and
0.42, respectively). In contrast, accumulation mode parti-
cles (ACP) were highly correlated to 1-hour PM10, PM2.5
and UFP (Spearman correlation coefficients of 0.79, 0.75
and 0.70, respectively).
Changes in heart rate variability in response to particle
exposure
Table 3 shows the associations between 5-minute per-
sonal exposures to PNC and HR and HRV assessing
concurrent and exposures lagged up to 15 minutes. It
shows a slightly delayed response of HR and an immedi-
ate decrease in SDNN. Different responses of HR and
SDNN to PNC may be reasonable given the fact that
correlation between HR and SDNN differed substantially
between individuals with a median Spearman correlation
of −0.10 and a range between −0.53 and 0.55.
Associations between PNC and SDNN appear to be
more pronounced in individuals with diabetes than in
individuals with IGT (Figure 2). Exploratory analyses ex-
tending the time-lag between 5-minute personal expos-
ure to PNC and HR, SDNN or RMSSD up to one hour
showed no consistent pattern beyond 15 minutes.
We had previously shown associations between 1-
hour ambient air pollution concentrations and cardiac
function occurring up to a lag of 4 hours [17]. We had
chosen one hour intervals of exposure and ECG record-
ings a priori as we considered this the minimal time scale
for a central monitoring site in an urban background loca-
tion to represent population average exposures. In Table 4nts from 191 study visits and 1 hour of ambient particle
07 and December 2008
25% Median 75% Max IQR
6,354 11,134 21,987 698,225 15,633
)
4,892 7,629 12,049 80,858 7,157
1,020 1,657 2,615 17,377 1,595
8.4 15.3 24.4 159.8 16.0
5.8 10.9 18.1 106.5 12.3
4.7 10.8 16.5 33.8 11.8
63.3 81.3 92.8 100.0 29.5
s, PM10: particulate matter with an aerodynamic diameter <10 μm, PM2.5:
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Figure 1 Example of personal measurements of PNC. Data was collected starting and ending at the KORA Study Center on November 27th 2007.
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personal PNC and ambient UFP, ACP, PM10 and PM2.5
and concurrent measures of HR and HRV over 1-hour.
No consistent associations between personal or ambient
particles number concentrations (PNC, UFP, ACP) and
HR were observed. In contrast, PM10 and PM2.5 were as-
sociated both with SDNN and RMSSD as reported previ-
ously [17]. The association between PM2.5 and HRV was
stronger in individuals with IGT than those with type 2
diabetes, but the differences did not achieve statistical sig-
nificance. In line with our results, Chan and colleagues
observed significant decreases in SDNN and RMSSD in
association with an increase of 10,000 particles/cm3 in
personally measured particles in the size range between
20 nm and 1 μm in a prospective panel study [22]. Ad-
verse changes in HR and HRV were also observed in asso-
ciation with ambient UFP in panel or cross-over studies
[23-28] and with concentrated UFP in controlled chamber
studies [29,30] albeit some associations were not signifi-
cant. However, some studies reported no or even positive
associations between HRV and UFP [31-33].
Effect estimates were larger for the 1-hour PM2.5 than
for personal PNC and associations between 1-hour PM2.5Table 3 Associations between personal measurements of 5-m
5-minute ECG-measures
concurrent 0 - 4 min
%-change 95% CI %-change 95% CI
HR −0.06 −0.18; 0.07 0.23** 0.11; 0.3
SDNN −0.56* −1.02; −0.09 0.36 −0.11; 0
RMSSD −0.13 −0.74; 0.48 0.08 −0.54; 0
Analyses considered concurrent and up to 15-minutes delayed exposures and adju
increase of 16,000 particles cm−3.
*p-value <0.05, **p-value <0.01, CI: confidence interval, HR: heart rate, RMSSD: root
NN intervals.concentrations and 5-minute HRV strengthened when
adjusting for personal PNC (Figure 3). PM2.5 measured at
an urban background monitoring site quantifies the over-
all particulate matter level predominantly determined by
the meteorological conditions. In the present study, we
demonstrate therefore that particle exposures determined
by personal proximity to sources and by urban back-
ground levels both are associated with changes in cardiac
function on a very immediate time scale.
Earlier studies have observed associations between
hourly concentrations of PM2.5 and the onset of myocar-
dial infarction in Boston, MA [5] and Rochester, NY [6].
Moreover, times spent in traffic were associated with the
onset of myocardial infarction [7,8] and controlled ex-
posure studies suggest that effects of diesel exposures
might be enhanced by exercise [34]. Previous studies
have in many instances indicated that personal expo-
sures to PM2.5 or to gaseous pollutants are associated
with changes in HRV [26,35-51]. The study participants
ranged from healthy adults to patients with cardiovascu-
lar diseases or asthma and were studied in different set-
tings around the world. We had chosen individuals with
impaired glucose metabolism because individuals withinute average particle number concentrations and
5 - 9 min 10 - 14 min
%-change 95% CI %-change 95% CI
6 0.16* 0.04; 0.28 −0.01 −0.13; 0.11
.83 0.02 −0.45; 0.48 −0.15 −0.62; 0.32
.70 0.14 −0.48; 0.77 −0.16 −0.77; 0.46
sted for trend, meteorology and time of day. Effect estimates are shown for an






































concurrent 0 - 4min 5 - 9min 10 - 14min
Figure 2 Effects of personally measured 5-minute PNC on SDNN based on 5-minute ECG recordings in patients with diabetes or impaired
glucose tolerance. Effect estimates are shown for an increase of 16,000 particles cm−3.
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pollution [2-4]. A study of controlled human exposures
to concentrated ultrafine particles showed immediate ef-
fects on subjects with metabolic syndrome, however, did
not observe changes in HRV one hour after the exposure
[30]. In contrast, in a study in subjects with type 2 dia-
betes indicated a decrease in the high frequency compo-
nent of heart rate variability and increased heart rates
persisting up to 48 hours [16]. Furthermore, there is an
emerging body of evidence linking ambient air quality as
one of the risk factors to type 2 diabetes [52]. Data from
controlled animal experiments [53] as well as analyses in
prospective population-based cohort studies [54-58] sup-
port this association. Systemic inflammation, activation of
innate immunity in the lung and an imbalance of the
autonomic nervous system induced by air pollution expo-
sures jointly potentially provide the link to insulin resist-
ance and diabetes exacerbation [52]. Sudden changes inTable 4 Associations between ambient 1-hour average air po
1-hour average ECG-measures
HR SDNN
%-change 95% CI %-chan
Personal PNC 0.13 −0.19; 0.45 −0.93†
UFP 0.40 −0.16; 0.95 0.99
ACP 0.35 −0.39; 1.09 −0.30
PM10 0.67 −0.20; 1.54 −2.78
*
PM2.5 0.63 −0.44; 1.71 −3.27
*
Analyses considered concurrent exposures and adjusted for trend, meteorology and
as given in Table 2.
†p-value <0.1, *p-value <0.05, **p-value <0.01, CI: confidence interval, HR: heart rate
deviation of NN-intervals, PNC: Particle number concentrations, PM10: particulate m
aerodynamic diameter <2.5μm, UFP: ultrafine particles (10-100μm); ACP: accumulatcardiac function may predispose susceptible individuals to
sudden cardiac deaths during episodes with elevated par-
ticle concentrations [59]. Most likely, different underlying
intrinsic mechanisms are activated by 5-minute PNC and
1-hour PM2.5. We hypothesize that shortly elevated PNC
may activate irritant receptors and lead thereby to changes
in the autonomic control [60]. In contrast, we hypothesize
that the changes in HRV observed in association with
PM2.5 are associated with an activation of host defense on
an alveolar level, which may involve translocation of par-
ticle components, immediate systemic oxidative stress re-
sponse and an activation of leukocytes [52].
Sensitivity analyses
Associations were robust in sensitivity analyses and a
summary is given in Figure 4 for the association be-
tween personally measured personal PNC and SDNN.
No statistically significant difference was observed inllution concentrations at the central monitoring site and
RMSSD
ge 95% CI %-change 95% CI
−2.01; 0.16 0.53 −0.70;1.77
−0.66; 2.64 −0.12 −2.40; 2.21
−2.23; 1.64 −1.58 −5.19; 2.18
−4.98; −0.59 −5.00* −8.88; −0.95
−5.84; −0.69 −6.86** −11.73; −1.72
time of day. Effect estimates are shown for an increase in interquartile range
, RMSSD: root mean square of successive differences, SDNN: standard
atter with an aerodynamic diameter <10μm, PM2.5: particulate matter with an








































   single    two-pollutant
model
   single    two-pollutant
model
   single    two-pollutant
model
HR SDNN RMSSD
Figure 3 Two pollutant models for 5-minute personal PNC and 1-hour ambient PM2.5 on 5-minute HR and HRV parameters. in patients
with diabetes or impaired glucose tolerance. Effect estimates are shown for an increase of 16,000 particles cm−3 and 12 μg m−3 PM2.5.
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By selecting individuals with impaired glucose toler-
ance, we intended to study the impact of particles in in-
dividuals who were not heavily treated by beta-blockers
or statins as these medications may obliterate the ef-
fects of particle exposures [61,62].
Excluding time periods when the participants recorded
ETS exposures or cooking rendered consistent results,
but suggested that indoor sources contributed to the ob-
served associations. We employed two different ways to
adjust for physical activity. Neither adjusting for the
diary entries of physical activity nor for heart rate did
change the effect estimates. Models including personal
noise exposure showed stronger associations with per-
sonal PNC (Figure 3) and increased 5-minute SDNN
(3.35% [95% CI: 2.95% ; 4.11%] per 5 db[A]) as reported
previously [63]. These analyses suggested that the associ-
ations of PNC and noise with ECG-parameters were po-
tentially confounding each other. To further test theimpact of the model choices, we conducted sensitivity
analyses for the immediate effect of PNC on SDNN. In-
cluding a time trend within the measurements or includ-
ing the previous segments of SDNN as a predictor did
not change the effect estimates substantially (5-minute
SDNN: −0.56% [−0.98%;-0.13%] or −0.42% [−0.77%;-
0.06%] per 16,000 cm−3 PNC, respectively).
Limitations
The study assessed personal measurements of PNC
which is a novel marker for personal exposure to fresh
combustion particles. The study thereby overcomes one
large limitation of previous panel studies. By employing
direct measurements of PNC it also provides different
and novel information compared to studies of personal
PM2.5 or gaseous pollutants [26,35-49]. However, the
measurement devices are usually operated by technical
personnel to measure indoor and outdoor particle con-
centrations and were not designed for study participants.
% Change per 16,000 Particles/cm3
-2.0 -1.5 -1.0 -0.5 0 0.5
Main effect
Without persons with intake of beta-blockers
Without persons with intake of statins
Without visits with ETS
Without visits with cooking
+ Adjustment for physical activity
+ Adjustment for heart rate
+ Adjustment for noise
+ Adjustment for ambient PM2.5 (1h)
Figure 4 Sensitivity analyses of the association between concurrent exposure to personally measured PNC and SDNN. *Regression
coefficient as reported in Table 3.
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the planned hourly measurements albeit stringent exam-
iner training, review of the instruction sessions by audio-
tape, and written instructions for the participants. The
missing measurements had no certain pattern and were
related to diligence in following the instructions by the
study participants. Diaries were kept by the partici-
pants, but no geographic positioning system data was
acquired. ECG data and personal PNC data were proc-
essed independently. While the examiners and the partici-
pants were aware of the study hypotheses, information on
their HR was not available and levels of PNC were not dis-
cussed with respect to limit or guideline values as these
do not exist.
Timing of the measurements were based on recorded
times from the instruments and the study protocols. Dis-
crepant times were checked individually, discussed with
the study nurses and corrected wherever possible.
Each day’s measurement provided control data for the
individual and correlation within the day and the indi-
vidual was considered. Analyses proved to be relatively
robust against other assumptions of the covariance
structure. Confounding by physical activity, a potentially
important individual time-varying factor was considered
but did not prove to be strong and resulted in changes
of the effect estimates of less than 10%.
There were no statistically significant differences with
respect to age, body mass index, HbA1c concentrations,
history of cardiovascular disease and medication use when
comparing the study participants to all individuals with ei-
ther diabetes or IGT in the underlying sample of the
KORA cohort study. Participants of the panel study were
more likely to be unemployed, many of them already re-
tired. In addition, the proportion of ex-smokers was
higher in the present study than in the overall sample.As this study is assessing short-term impacts of urban
area ambient particulate matter, it does not address the
question, whether long-term exposure to particulate
matter is associated with an increased risk for incident
diabetes as recently shown [54-58]. However, the data
reported here provides evidence that short-term expos-
ure to ambient particulate matter may contribute to car-
diovascular disease exacerbation in individuals with
impaired glucose metabolism or diabetes.
Conclusion
The data presented here shows changes in HRV associ-
ated with personally measured PNC and ambient PM2.5
suggesting that both freshly emitted ultrafine particles as
well as aged aerosol in urban areas are associated with
changes in cardiac function. The study suggests that
personal activities and elevated particle concentrations
in micro-environments may modify personal exposures
and thereby impact on cardiac function. The study was
conducted in individuals with type 2 diabetes and IGT
suggesting that these subgroups of the population
might be at risk for cardiovascular disease exacerbation




A prospective panel study was conducted in Augsburg,
Germany, between March 19, 2007 and December 17,
2008. Individuals with diabetes mellitus type 2 or im-
paired glucose tolerance (IGT) were recruited from an
ongoing examination of 3,080 individuals as part of the
KORA F4 cohort study (Cooperative Health Research in
the Region of Augsburg) as described in detail elsewhere
[18,19]. Type 2 diabetes was defined on based on a
Peters et al. Particle and Fibre Toxicology  (2015) 12:7 Page 8 of 11validated physician diagnosis, or newly diagnosed dia-
betes (≥7.0 mmol⁄l fasting or ≥ 11.1 mmol⁄l 2-h glucose)
determined by an oral glucose tolerance test. IGT was de-
fined according to the 1999 World Health Organization
diagnostic criteria [64]. Exclusion criteria for the present
study were 1) current active smoking, 2) intake of platelet
aggregation inhibitors except for acetylsalicylic acid, 3) a
myocardial infarction and/or interventional procedure
(PTCA, bypass surgery) less than 6 months before the be-
ginning of the study, and 4) chronic inflammatory diseases
such as Crohn’s disease, colitis ulcerosa, and rheumatoid
arthritis. Furthermore, individuals were not included in
case of 1) an implanted pacemaker, 2) atrial fibrillation, 3)
allergy to latex, and 4) thrombosis or shunt in an arm to
standardize HRV analyses. All individuals participated in
repeated visits scheduled every 4–6 weeks on the same
weekday and at the same time of the day.
Ethics and consent statement
The study was conducted in compliance with the Helsinki
Declaration. Ethical approval for the study was granted by
the Ethics Committee of the Bayerische Landesärztekammer,
München, Germany. The study protocol including the
participant information and the consent form were part of
the ethics review. The study participants gave informed
written consent before entering into the study.
ECG monitoring
In the personal monitoring program, participants were
equipped for five to six hours with an electrocardiogram
(ECG) device during their second up to the fifth visit as
described previously [17]. ECGs were recorded with a
12-lead Mortara H12 digital Holter recorder (Mortara
Instrument, Milwaukee, WI, USA). Analyses of heart
rate variability were restricted to ECGs that had at least
200 beats available for 5-minute intervals. Heart rate (HR)
and time domain parameters of HRV, the standard devi-
ation of all normal-to-normal (NN) intervals (SDNN), and
the root mean square of successive NN interval differ-
ences (RMSSD) were determined on a 5-minute and an
hourly basis. Only individuals with at least one ECG re-
cording with duration of at least two hours were used
for analysis.
Personal particle number concentration monitoring
Personal exposure to PNC was measured using a port-
able condensation particle counter model 3007 (TSI
Inc., USA) which covered a diameter range from 10 nm
to 1 μm. Participants were instructed on how to restart
the measurements if tilting might have resulted in an au-
tomated stop of the measurements. They carried the de-
vice in a specially designed carrier bag within an inlet at
the top. Moreover, participants were asked to keep a
diary on their activities during the 5–6 hours of personalmeasurements including information on times spent in-
doors or outdoors, times spent in traffic, indoor activ-
ities such as cooking and sources such as environmental
tobacco smoke exposures (ETS). The participants were
instructed to always keep the device close by, but at least
within the same room at a central location. Diary infor-
mation was checked for plausibility and used to process
the measurement data. In four instances, participants
did not carry the PNC device with them for short pe-
riods of time (8 minutes, 10 minutes, 30 minutes or
1 hour). These data were excluded from the analyses.
Usually, measurements started around 7:30 a.m.; partici-
pants were free to go wherever they liked and returned
at around 1 p.m. Three portable condensation particle
counters were employed during the study. All of them
were serviced before the start of the study and compari-
son measurements were conducted in March 2007. Add-
itional service periods were conducted every six months.
More detail is provided in [20].
Central site air pollution monitoring
Ambient air pollution was measured at a central meas-
urement site in Augsburg throughout the complete
study period as described previously [65,66]. The meas-
urement location was in urban background approxi-
mately 1 km to the south-east of the city center. Particle
mass concentrations of PM2.5 and PM10 (particulate
matter ≤ 2.5 or 10 μm in aerodynamic diameter, respect-
ively) were measured by two separate Tapered Element
Oscillating Microbalance (TEOM, model 1400ab, Thermo
Fisher Scientific Inc., USA). To correct the PM measure-
ments for aerosol volatility effects, each TEOM was
equipped with a Filter Dynamics Measurement System
(FDMS, model 8500b, Thermo Fisher Scientific Inc.,
USA). Particle size distributions in the range from 3–
900 nm were measured by a custom-built Twin Differen-
tial Mobility Particle Sizer (TDMPS) system consisting of
two cylindrical, Vienna-type Differential Mobility Ana-
lyzers (DMA) covering complementary size ranges (3 to
23 nm as well as 18 to 900 nm). For the analysis we
used the size fraction of ultrafine particles from 10 to
100 nm (ambient UFP) and of accumulation mode
particles from 100 to 800 (ambient ACP).
Statistical analyses
Repeated continuous outcome data was analyzed using
mixed models with random patient effects to accommo-
date repeated measures and to account for unobserved
heterogeneity of the data. To account for dependencies
of the outcome measures, covariance structure consid-
ered autocorrelation of the first order for measurements
of the same day and correlation between measurements
of the same individual at days apart. This was done
within the framework of additive mixed models to allow
Peters et al. Particle and Fibre Toxicology  (2015) 12:7 Page 9 of 11for semi-parametric and non-parametric exposure-
response functions. Models were selected separately for
HR, SDNN, and RMSSD as described previously [17].
Final models included for HR: time trend (linear), time of
day (morning vs. afternoon), 1-hour air temperature (lag
2, polynomial of degree 2), 1-hour relative humidity (lag 1,
linear); for SDNN: time trend (linear), time of day (morn-
ing vs. afternoon), 1-hour air temperature (concurrent,
linear), 1-hour relative humidity (concurrent, linear) ; and
for RMSSD: time trend (linear), time of day (morning vs.
afternoon), 1-hour air temperature (lag 7, linear), 1-hour
relative humidity (lag 4, linear).
Models were adjusted for ambient meteorology and
temporal trends. Penalized splines were used to allow
for non-linear confounder adjustment. Results are pre-
sented as %-change from the mean per 16,000 ultrafine
particles cm−3 or the respective interquartile ranges to-
gether with 95% confidence intervals. A number of sen-
sitivity analyses were conducted including models
adjusting for personal 5-minute noise exposure mea-
sured as A-weighted equivalent continuous sound pres-
sure levels (Leq) reported in units of A-weighted
decibels [dB(A)] (Spark® model 703; Larson Davis Inc.,
Depew, NY, USA) as described elsewhere [63]. Data were
analyzed using SAS statistical software (version 9.1; SAS
Institute Inc., Cary, NC, USA).
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